While there remains controversy concerning whether development of CD4 or CD8 immunity will best predict host-resistance [43], [44], there is also concern that vaccination may augment induction of Tregs to block effective tumor immunity [45], [46]. This evidence concerns the gene CD8A and neoplasm.